204-505-9

Applied Filters:

Keyword:'204-505-9'

Showing 1-23 of 23 results for "204-505-9" within Technical Documents

J. Biol. Chem. 273, 21473 (1998). 9. Park, I-K., and Soderling, T.R., J. Biol. Chem. 270, 30464 (1995). 10. Nakamura,Y., et al., Neurosci,. Lett. 204 61 (1996). 11. Yano, S., et al., Nature

Quality Control Ranges: MILLIPLEX® MAP Mouse Cytokine/Chemokine Panel

Control 1 102 - 213 pg/mL IL-7 Control 1 95 - 197 pg/mL MCP-1 Control 1 96 - 200 pg/mL Control 2 505 - 1048 pg/mL Control 2 470 - 977 pg/mL

XP725 Antibody Number-Lot Number 071M4826

474 475 476 5.6 405 406 407 408 429 430 431 432 453 454 455 456 477 478 479 480 6.1 481 482 483 484 505 506 507 508 529 530 531 532 553 554 555 556 6.2 485 486 487 488 509

Readycult Federal Register Final Rule October 2002

........ 507, 525.2, 508.1, 505, 551.1. 26. Atrazine 2 ........................................................................................ 507, 525.2, 508.1, 505, 551.1. .................

Protein Tyrosine Phosphatases- Potential Roles in Disease

5953 (1991). 8. Gu, M.X., et al., Proc. Natl. Acad. Sci. USA, 88, 5867-5871 (1991). 9. Su, J., et al., Curr. Biol., 9, 505-511 (1999). 10. Alexander, D.R., Semin. Immunol., 12, 349-359 (2000). 11. Binstadt

Article: Prognostic nomogram incorporating neutrophil-to-lymphocyte ratio for early mortality in decompensated liver cirrhosis

no- mogram for acute-on-chronic hepatitis B liver failure, J. Gastroenterol. Hepatol. 32 (2017) 497–505. [14] T. Horvatits, A. Drolz, K. Roedl, et al., Serum bile acids as marker for acute de- compensation

ExPlore with Confidence: Prestige Antibodies Breast Cancer Research

homologous recombination deficiency in triple-negative breast cancers. Cancer Discov 2015 May; 5(5):488-505. Epub 2015 Mar 13. 90. Xiang YJ et al. Absence of Gamma-Interferon-Inducible Lysosomal Thiol Reductase

HPLC Reagents

constituted and effective at the time of shipment, or is an article which may not, under Sections 404 or 505 of the Act, be introduced into interstate commerce. EXCEPT FOR THE WARRANTIES ABOVE, EMD MAKES NO

XP725 Antibody List Lot 129K4831

006149.2 y n/d y 497 Neurofibromin N3662 4763 NF1 M NP_000258.1,NP_001035957.1 ,NP_001121619.1 y y y 505 NF-kB N8523 4790 NFKB1 M NP_001158884.1 y y n/d 378 IkBa I0505 4792 NFKBIA P NP_065390.1 y y y 491

XP725 Antibody List Lot 129K4830

Inhibitor Sourcebook 3rd Edition

200 nM or 3.8 µM using pNPP or phosphorylated Ick 505 peptide as a substrate, respectively). Does not effectively inhibit PTPIB (IC50 Ick 505 peptide as a substrate). The phenanthrenedione group

XP725 Antibody List Lot 089K4791

User Guide accu-jet® S - multi language

devolução. Colocar o número de devolução no exterior do pacote de modo bem visível. 9 Reparação 204 Instruções de utilização 997418 Endereço de contacto Alemanha: BRAND GMBH + CO KG Otto-Schott-Straße

XP725 Antibody List

http://www.sigmaaldrich.com/ProductLookup.html?ProdNo=G7670&Brand=SIGMA� 3 9 3 9 3 9 3 9 3 9 3 9 3 9 T 3 3 9 3 9 334 HDAC-7 H6663 56233, 51564 HDAC7A,Hdac7a NP_062518.2,NP_057680.3 M y y n/d

Organic and Molecular Electronics

.20 0.97 SBD-4 504 92±2 2.2 4.4 9.5±1.0 1.54 BSB-Cz 462 99±1 1.0 10 0.32±0.05 2.70 BSB-Me 505 92±3 1.0 9.1 0.78±0.10 2.66 BSB-OMe 530 90±1 1.2 7.2 0.90±0.10 2.33 BSB-CN 586 55±2 1.5 3.7

List of Antibodies

Neurofilament 68 N5139 M y n/d n/d 503 Neurofilament 160/200 N2912 M y y y 504 Anti Cy3+Cy5 C0992 M NA NA NA 505 NF-κB N8523 M y y n/d 506 NAK (NFκB-Activating Kinase) N2661 M y n/d y 507 NG2 N8912 M n/d n/d

XP725 Antibody List 013M4793

N5139 4747 NEFL NP_006149.2 M y n/d n/d 503 Neurofilament 160/200 N2912 M y y y 504 Anti Cy3+Cy5 C0992 505 NF-κB N8523 18033, 4790 NFKB1,Nfkb1 NP_032715.2,NP_003989.2 M y y n/d 506 NAK (NFκB-Activating Kinase

XP725 Worksheet for Lot Number 071M4826

E9653 502 3 3 3 6 Endothelial Cells E9653 503 3 3 3 7 Endothelin E0771 504 3 3 3 8 Endothelin E0771 505 3 3 4 1 Epidermal Growth Factor E2520 506 3 3 4 2 Epidermal Growth Factor E2520 507 3 3 4 3

MAPK: Antibodies, Proteins, Kits, siRNA and Reagents

-phospho-PKCι (Thr555)/PKCλ (Thr563) H M WB APur Rb IgG 100 µL 07-881 PKC ι, active KA 10 µg 14-505 PKCμ Antibody Anti-phospho-PKCµ/PKD (Ser742) H M WB APur Rb IgG 100 µL 07-882 PKCµ, active

Halal Certificate

ORGANIC (NOP) W232314 A71757 HC-24SIAS53 504. COCOA EXTRACT, BLEND, FG W584649 B65604 HC-24SIBW27 505. COCONUT OIL, VIRGIN, CERTIFIED ORGANIC (NOP) W530155 B15645 HC-24SI1V80 506. COFFEE OIL, ROASTED

Halal Certificate

ORGANIC (NOP) W232314 A71757 HC-22SI4A51 504. COCOA EXTRACT, BLEND, FG W584649 B65604 HC-22SIUH25 505. COCONUT OIL, VIRGIN, CERTIFIED ORGANIC (NOP) W530155 B15645 HC-22SIZG78 506. COFFEE OIL, ROASTED

Chrombook 2015 - The world of chromatography in your hands

Heptanophenone 9. Ocatnophenone Mobile phase A: Water B: Acetonitrile Gradient 0 min 55 % B 0.8 min 55 – 100 % B 0.9 – 2 min re-equilibration with 55 % B Flow rate 1.1 mL/min Pressure 505 bar Detection

Cytoskeletal Signaling Antibodies, Reagents and Kits

anti-phospho-PKCι (Thr555)/PKCλ (Thr563) H M WB APur Rb IgG 100 µL 07-881 Protein PKCι, active KA 10 µg 14-505 PKCµ Polyclonal Antibody Anti-phospho-PKCµ/PKD (Ser742) H M WB APur Rb IgG 100 µL 07-882